Correlation Between Vanishing White Matter Disease and Novel Heterozygous EIF2B3 Variants Using Next-Generation Sequencing: A Case Report
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Vanishing white matter (VWM) disease is an autosomal recessive disorder that affects the central nervous system of a patient, and is caused by the development of pathogenic mutations in any of the EIF2B1-5 genes. Any dysfunction of the EIF2B1-5 gene encoded eIF2B causes stress-provoked episodic rapid neurological deterioration in the patient, followed by a chronic progressive disease course. We present the case of a patient with an infantile-onset VWM with the pre-described specific clinical course, subsequent neurological aggravation induced by each viral infection, and the noted consequent progression into a comatose state. Although the initial brain magnetic resonance imaging did not reveal specific pathognomonic signs of VWM to distinguish it from other types of demyelinating leukodystrophy, the next-generation sequencing studies identified heterozygous missense variants in EIF2B3, including a novel variant in exon 7 (C706G), as well as a 0.008% frequency reported variant in exon 2 (T89C). Hence, the characteristic of unbiased genomic sequencing can clinically affect patient care and decision-making, especially in terms of the consideration of genetic disorders such as leukoencephalopathy in pediatric patients.
Abstract
Vanishing white matter (VWM) disease is an autosomal recessive disorder that affects the central nervous system of a patient, and is caused by the development of pathogenic mutations in any of the EIF2B1-5 genes. Any dysfunction of the EIF2B1-5 gene encoded eIF2B causes stress-provoked episodic rapid neurological deterioration in the patient, followed by a chronic progressive disease course. We present the case of a patient with an infantile-onset VWM with the pre-described specific clinical course, subsequent neurological aggravation induced by each viral infection, and the noted consequent progression into a comatose state. Although the initial brain magnetic resonance imaging did not reveal specific pathognomonic signs of VWM to distinguish it from other types of demyelinating leukodystrophy, the next-generation sequencing studies identified heterozygous missense variants in EIF2B3, including a novel variant in exon 7 (C706G), as well as a 0.008% frequency reported variant in exon 2 (T89C). Hence, the characteristic of unbiased genomic sequencing can clinically affect patient care and decision-making, especially in terms of the consideration of genetic disorders such as leukoencephalopathy in pediatric patients.
참고문헌 (10)
- van der Knaap MS, "Vanishing white matter disease", Lancet Neurol, 5, pp.413~423 (2006)
- van der Knaap MS, "Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter", Ann Neurol, 51, pp.264~270 (2002)
- Fogli A, "Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients", Eur J Hum Genet, 12, pp.561~566 (2004)
- Pronk JC, "Vanishing white matter disease : a review with focus on its genetics", Ment Retard Dev Disabil Res Rev, 12, pp.123~128 (2006)
- 오자영, "Identification of a Heterozygous SPG11 Mutation by Clinical Exome Sequencing in a Patient With Hereditary Spastic Paraplegia: A Case Report", Annals of Rehabilitation Medicine, 40(6), pp.1129~1134 (2016), 대한재활의학회
- Ding XQ, "Imaging evidence of early brain tissue degeneration in patients with vanishing white matter disease : a multimodal MR study", J Magn Reson Imaging, 35, pp.926~932 (2012)
- van der Lei HD, "Restricted diffusion in vanishing white matter", Arch Neurol, 69, pp.723~727 (2012)
- Zhang H, "Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up", PLoS One, 10, pp.e0118001~ (2015)
- La Piana R, "Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation", Arch Neurol, 69, pp.765~768 (2012)
- Gowda VK, "Case of Childhood ataxia with central nervous system hypomyelination with a novel mutation in EIF2B3 gene", J Pediatr Neurosci, 12, pp.196~198 (2017)